Stay informed and entertained with our collection of news videos, bringing you the latest updates and information. Watch now to stay up-to-date!
The highlight of this week was the much-awaited jobs report for September that was released after the longest government shutdown in the U.S. history came to an end. Minutes of the latest Fed policy session and the survey data on the manufacturing sector also gained attention. In Europe, inflation data from the U.K. was in focus, while economic output figures for the Japanese economy raised concern in Asia.
Economics news flow from the U.S. was slow due to the federal government shutdown. The highlight was the minutes of the latest Federal Reserve policy session and the mortgage applications data. In Europe, economic indicators in Germany rang alarm bells and kindled speculation of a recession. In Asia-Pacific, New Zealand announced the latest interest rate decision. In other news, the World Bank released economic updates for regions covering Asia, Middle East and Central and Eastern Europe.
First half of this week the focus was on efforts to avoid a government shutdown in the U.S. However, talks to avert one failed and an almost total blackout of federal government began on October 1, Wednesday. The weekly claims data due on Thursday and the job report on Friday from the Bureau of Labor Statistics were not released. In Europe, inflation data in the euro area raised concern and the latest interest rate decision from India was among the main news in Asia.
Revised economic growth data for the second quarter and the Fed chief Jerome Powell’s speech were the highlights in the U.S. on a busy week for economic news. Housing market data also gained attention. Elsewhere, the Paris-based think tank OECD released its latest projection for the global economy that threw light on the impact of the U.S. trade tariffs. In Europe, the interest rate decision announcement by Switzerland’s central bank was in focus.
April 20, 2026 02:21 ETAstraZeneca PLC (AZN) on Monday said its pivotal Phase III MIRANDA trial of tozorakimab in patients with Chronic Obstructive Pulmonary Disease met its primary endpoint, demonstrating a statistically significant and clinically meaningful reduction in exacerbations. The study evaluated patients with...
April 14, 2026 07:40 ETLigand Pharmaceuticals Inc. (LGND) announced Tuesday that its partner Travere Therapeutics, Inc. (TVTX) has received approval from the U.S. Food and Drug Administration (FDA) for FILSPARI (sparsentan) to reduce proteinuria in adult and pediatric patients aged 8 years and older with focal segmental glomerulosclerosis...
May 04, 2026 09:29 ETa2 Milk Company Ltd. (ACOPF, A2M.AX), a dairy company, announced a recall of select infant milk formula, manufactured by Synlait Milk Limited and sold only in the United States, citing the presence of cereulide. The recall involves three batches of a2 Platinum USA label infant milk formula, comprising...